Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.PerkinElmer, a provider of technology, services and solutions to the diagnostics, detection and analysis and photonics markets, has launched its Operetta system, a benchtop instrument that provides high content screening and high content analysis capabilities to drug discovery and cellular science research laboratories.
Subscribe to our email newsletter
According to the company, Operetta employs its proprietary new Harmony software which provides researchers with easy-to-use building blocks for creating user configurable workflows via simple step-by-step procedures. An extensive range of ready-made solutions for frequently used image analysis tasks is also pre-installed. The Harmony software provides tools to develop high content assays, image analysis storage and retrieval, as well as remote access capability, the company added.
The Operetta instrument is designed to reportedly allow maximum functionality in the smallest possible footprint. A large field of view and multi-processor technology facilitates high speed data acquisition and analysis. A wide range of objectives and filters, bar-coded for error-free operation, enables a wide range of assays and plates, said PerkinElmer.
Richard Eglen, president of bio-discovery at PerkinElmer, said: “The Operetta platform and Harmony software extend PerkinElmer’s portfolio in cellular imaging and bring the benefits of high content screening and high content analysis to almost any life sciences laboratory.
“Our expertise in cellular imaging provides us with unique insights into common issues encountered in implementing high content screening research. We are now providing this critical knowledge to Operetta users, so they can easily and rapidly optimize imaging studies for their cell science research.”